Topical Targeting Therapies for Sexually Transmitted Diseases

被引:2
作者
Andreani, Tatiana [1 ,2 ,3 ]
Macedo, Ana Sofia [1 ]
Ferreira, Sandra F. [1 ]
Silva, Amelia M. [2 ,3 ]
Rosmaninho, Aristoteles [4 ]
Souto, Eliana B. [1 ,5 ]
机构
[1] UFP, Fac Hlth Sci, Dept Pharmaceut Technol, P-4200150 Oporto, Portugal
[2] Univ Tras Os Montes & Alto Douro, Dept Biol & Environm, Vila Real, Portugal
[3] Ctr Res & Technol Agroenvironm & Biol Sci, Vila Real, Portugal
[4] Hosp Santo Antonio, Dept Dermatol, CHP EPE, Oporto, Portugal
[5] Univ Tras Os Montes & Alto Douro, IBB, CGB, UTAD, Vila Real, Portugal
关键词
Sexual transmitted diseases; nanotechnology; diagnostics; prevention; topical therapy; SOLID LIPID NANOPARTICLES; NEISSERIA-GONORRHOEAE; CHLAMYDIAL INFECTIONS; DENDRIMER MICROBICIDE; DERMAL DELIVERY; AMPLICOR PCR; SPL7013; GEL; FORMULATION; PREVENTION; HIV;
D O I
10.2174/157341312801784348
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The past years have witnessed a persistent deterioration of sexual health, especially among young adults. The most concerning problems are sexually transmitted diseases and non-planned pregnancies that cost millions of dollars in healthcare. Sexually transmitted diseases are usually represented by cutaneous signs which may provide a portal of entry for the transmission of other infections, such as HIV. Skin is a widely used route of delivery of drugs locally, and also potentially promising pathway for systemic targeting. Skin contributes to the physical and chemical protection of the body, providing an important barrier against topical drug administration. However, it may be overcome by nanotechnology-based systems, especially in skin diseases, reducing the side effects. Different approaches have been focused on nanotechnology, not only in the treatment of sexually transmitted diseases, but also in diagnostics and prevention of these infections. The present paper highlights recent advances in the nanotechnology-based systems for the diagnostic, prevention and topical treatment of sexually transmitted diseases.
引用
收藏
页码:486 / 490
页数:5
相关论文
共 76 条
[1]   Nanomaterials as Analytical Tools for Genosensors [J].
Abu Salah, Khaled ;
Alrokyan, Salman A. ;
Khan, Muhammad Naziruddin ;
Ansari, Anees Ahmad .
SENSORS, 2010, 10 (01) :963-993
[2]   DNA-Based Applications in Nanobiotechnology [J].
Abu-Salah, Khalid M. ;
Ansari, Anees A. ;
Alrokayan, Salman A. .
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2010,
[3]   Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting [J].
Alex, M. R. Aji ;
Chacko, A. J. ;
Jose, S. ;
Souto, E. B. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 42 (1-2) :11-18
[4]   Formulation of Tenofovir-Loaded Functionalized Solid Lipid Nanoparticles Intended for HIV Prevention [J].
Alukda, Dima ;
Sturgis, Timothy ;
Youan, Bi-Botti C. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (08) :3345-3356
[5]  
Amiji Mansoor M, 2006, Discov Med, V6, P157
[6]   In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir? [J].
Andrei, G ;
De Clercq, E ;
Snoeck, R .
ANTIVIRAL RESEARCH, 2004, 61 (03) :181-187
[7]   Sol-gel derived nano-structured zinc oxide film for sexually transmitted disease sensor [J].
Ansari, Anees A. ;
Singh, Renu ;
Sumana, G. ;
Malhotra, B. D. .
ANALYST, 2009, 134 (05) :997-1002
[8]   Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment [J].
Baert, Lieven ;
van 't Klooster, Gerben ;
Dries, Willy ;
Francois, Marc ;
Wouters, Alfons ;
Basstanie, Esther ;
Iterbeke, Koen ;
Stappers, Fred ;
Stevens, Paul ;
Schueller, Laurent ;
Van Remoortere, Pieter ;
Kraus, Guenter ;
Wigerinck, Piet ;
Rosier, Jan .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2009, 72 (03) :502-508
[9]   Multiplex AMPLICOR PCR screening for Chlamydia trachomatis and Neisseria gonorrhoeae in women attending non-sexually transmitted disease clinics [J].
Bassiri, M ;
Mardh, PA ;
Domeika, M ;
Borendal, N ;
Capdevila, CC ;
Creatsas, G ;
Douvier, S ;
Guashino, S ;
HenrySuchet, J ;
Hopwood, J ;
Kliment, M ;
Lazdane, G ;
Mallinson, H ;
Nagy, E ;
Neuer, A ;
Nottin, P ;
Palacios, S ;
Penngy, G ;
Peterek, J ;
Rebelo, D ;
vanSanten, M ;
Tchoudomirova, K ;
Templeton, A ;
Unzeitig, V .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (10) :2556-2560
[10]   The global HIV/AIDS vaccine enterprise: Scientific strategic plan [J].
Bhan, MK ;
Berkley, S ;
DeWilde, M ;
Esparza, J ;
Fauci, AS ;
Gayle, H ;
Johnston, MI ;
Kaleebu, P ;
Kazatch-Kine, MD ;
Klausner, RD ;
Lander, ES ;
Makgoba, MW ;
Mocumbi, P ;
Piot, P ;
Quintana-Trias, O ;
Snow, W ;
Walport, MJ ;
Wigzell, H .
PLOS MEDICINE, 2005, 2 (02) :111-121